Skip to main content
OpenTrials
Completed

NCT Number: NCT03390257

Study to Evaluate the Safety and Initial Effectiveness of the Sinusway™ for Endoscopy of Sinuses in Conjunction With BSD

3NT flexible endoscope is a single-use disposable handheld endoscope that provides a means to visualize the nasal cavity and paranasal sinus space and deliver irrigation to treat the sinus ostia and spaces within the paranasal sinus cavities for diagnostic and therapeutic procedures

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

SF Otolaryngology, San Francisco, California, United States

Loading trial locations.

About this study

The rationale behind this feasibility study is to show that access and visualization of the nasal anatomy and paranasal sinuses (Maxillary, Frontal and Sphenoid sinuses) in conjunction with Balloon Sinus Dilation in patients suffering from symptoms attributable to sinusitis is feasible in the office and operating room settings; This is an essential step in the development of a combined dilation and visualization system that will allow visualization, dilation and lavage of the sinuses via their natural ostia during an office visit, and minimize radiation exposure, antibiotic use, multiple office visits, and cost.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patient indicated for balloon sinus dilation procedure by the ENT specialist
  • Patient age: adult (>18 years old)
  • Patients in general good health in the opinion of the investigator as determined by medical history and physical examination
  • A patient who is able to understand the requirements of the study, is willing to comply with its instructions and schedules, and agrees to sign the informed consent

Exclusion criteria

  • Known history of any significant medical disorder, which in the investigator's judgment contraindicates the patient's participation
  • Patients with known current or previous bleeding disorder receiving anticoagulants (e.g., chronic Coumadin treatment)

Treatment and study plan

3NT flexible endoscope

Device

The nasal anatomy will be accessed and viewed with the device during Balloon Sinus Dilation

Other names: Balloon sinus dilation

Primary outcomes

  1. Number of Adverse Device Effects

    Time frame: 4 hours

    Number of Adverse Device Effects is expected to be similar to the number reported in literature for Nasal Endoscopy

Secondary outcomes

  1. Percent of Sinuses Accessed and Visualized Successfully

    Time frame: 1 hour

    Physician evaluation of the ability to access and visualize the paranasal sinuses. will be recorded as done/not done/failed

  2. User Satisfaction (1-bad, 5-good)

    Time frame: 1 hour

    Physician satisfaction questionnaire

    (1-bad, 5-good)

Sponsors and collaborators

Lead sponsor

3NT Medical Ltd.

Industry

Registry information

Official study title

Safety and Effectiveness Evaluation of the Sinusway™ Device for Endoscopy of the Nasal Cavity and Paranasal Sinuses in Conjunction With Sinus Balloon Dilation

Important dates

Study start
2017
Primary completion
2018
Study completion
2019
First posted
Jan 4, 2018
Registry last updated
Dec 8, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.